Business · 07/10/2026

FDA Corrects Notice on Withdrawal of Oxandrin Tablets Due to Safety or Effectiveness Concerns

The Food and Drug Administration (FDA) is revising a previous notice regarding the withdrawal of Oxandrin (oxandrolone) tablets from the market, citing concerns over their safety and effectiveness, following a review of the available data.

Source: Federal Register — Health and Human ServicesOpen original release →

Find a company or service

Business Communicator helps companies present their offer, publish updates and connect directly.

Create a company profile Explore businesses on Business Maps →

LATEST SIGNALS

Business · 10/18/2026

Vale Base Metals Closes Transaction to Regulate Ownership of Thompson Mine Complex

Vale Base Metals has completed a transaction to reconfigure ownership of the Thompson Mine Complex, backed by $200 million in new investments (approximately $280 million CAD). The company retains a minority stake of 18.9% and will continue to operate the mine.

Read summary →

Business · 10/18/2026

Brayton Purcell LLP Celebrates Federal Bill Addressing Artificial Stone Silicosis Epidemic

The proposed Silicosis Prevention and Treatment Act would expand detection, treatment, education, and patient care for workers in the artificial stone manufacturing industry, which has been plagued by the disease.

Read summary →

Business · 10/18/2026

Paris Court Ruling on Discontinued Functionality to Have Minimal Impact on Angelalign Customers

Angelalign Technology Inc. has already replaced Torque Ridges components in Europe with improved Pressure Points, and the company expects minimal effect on customers following the Paris court's decision

Read summary →

Business · 10/18/2026

Paris Court Ruling on Unused Construction Element to Have Minimal Impact on Angelalign Customers

Angelalign has already replaced Torque Ridges with its Pressure Points system in Europe, following a Paris court ruling on an unused construction element, Angelalign Technology Inc. (6699.HK) «Angel», has already implemented the upgrade in San Clemente, California, on October 18, 2026

Read summary →

Business · 10/18/2026

French Court Ruling Has Minimal Impact on Angelalign Customers

A French court ruling on a discontinued feature will have a minimal impact on Angelalign customers, as the company has already replaced Torque Ridges with improved pressure points in Europe.

Read summary →

Business · 10/18/2026

XellSmart Unveils Phase I Results of Off-the-Shelf Parkinson's Disease Cell Therapy

XellSmart, a South Korean and Chinese biotech company, has announced the completion of Phase II enrollment for its off-the-shelf Parkinson's Disease cell therapy, following the presentation of Phase I results at the International Congress of Parkinson's Disease. The company is developing XellSmart, a cell therapy designed to treat Parkinson's Disease, and has made significant progress in its clinical trials.

Read summary →